Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

Related Articles by Review for PubMed (Select 11543871)

1.

Slow onset of CNS drugs: can changes in protein concentration account for the delay?

Kuhar MJ, Joyce AR.

Trends Pharmacol Sci. 2001 Sep;22(9):450-6. Review.

PMID:
11543871
2.

[Hepatic tolerance of atypical antipsychotic drugs].

Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora JF, Aubriot-Delmas B, Glikman J, Januel D.

Encephale. 2002 Nov-Dec;28(6 Pt 1):542-51. Review. French.

PMID:
12506267
3.

General anesthetics and long-term neurotoxicity.

Perouansky M.

Handb Exp Pharmacol. 2008;(182):143-57. doi: 10.1007/978-3-540-74806-9_7. Review.

PMID:
18175090
4.

Muscarinic acetylcholine receptors as CNS drug targets.

Langmead CJ, Watson J, Reavill C.

Pharmacol Ther. 2008 Feb;117(2):232-43. Epub 2007 Dec 20. Review.

PMID:
18082893
5.

[The action of oxidative stress induced by ethanol on the central nervous system (CNS)].

Augustyniak A, Michalak K, Skrzydlewska E.

Postepy Hig Med Dosw (Online). 2005;59:464-71. Review. Polish.

6.

[Acting out and psychoactive substances: alcohol, drugs, illicit substances].

Gillet C, Polard E, Mauduit N, Allain H.

Encephale. 2001 Jul-Aug;27(4):351-9. Review. French.

PMID:
11686057
7.

Tolerance to, and dependence on, some non-opiate psychotropic drugs.

Kalant H, LeBlanc AE, Gibbins RJ.

Pharmacol Rev. 1971 Sep;23(3):135-91. Review. No abstract available.

PMID:
4398655
8.

[Central mechanisms of predisposition to psychoactive substance dependence].

Anokhina IP, Vekshina NL, Veretinskaia AG.

Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(12):83-4. Review. Russian. No abstract available.

PMID:
9591078
10.

Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis.

Ma D, Guest PC, Bahn S.

Bioanalysis. 2009 Dec;1(9):1615-26. doi: 10.4155/bio.09.144. Review.

PMID:
21083107
11.

Targeted lipidomics: signaling lipids and drugs of abuse.

Rapaka RS, Piomelli D, Spiegel S, Bazan N, Dennis EA.

Prostaglandins Other Lipid Mediat. 2005 Sep;77(1-4):223-34. Review. No abstract available.

PMID:
16099407
12.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
13.

Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies.

Dean B.

Int J Neuropsychopharmacol. 2011 Aug;14(7):997-1012. doi: 10.1017/S1461145710001410. Epub 2010 Dec 15. Review.

PMID:
21156092
14.
15.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
16.

Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.

Kuroki T, Nagao N, Nakahara T.

Prog Brain Res. 2008;172:199-212. doi: 10.1016/S0079-6123(08)00910-2. Review.

PMID:
18772034
17.

Neuronal aspects of opiate dependence and tolerance in comparison to central depressants.

Herz A, Zieglgänsberger W, Schulz R, Fry JP, Satoh M.

Adv Exp Med Biol. 1977;85B:117-40. Review.

PMID:
22993
18.
19.

The pharmacology and toxicology of atypical antipsychotic agents.

Burns MJ.

J Toxicol Clin Toxicol. 2001;39(1):1-14. Review.

PMID:
11327216
20.

Pathophysiology of antipsychotic drug-induced movement disorders.

Casey DE.

J Clin Psychiatry. 2004;65 Suppl 9:25-8. Review.

PMID:
15189109
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk